Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, J1H 5N4, Canada
NCT Number: NCT01086124
The purpose of this study is to evaluate left ventricular systolic ejection fraction and anterior or apical akinesis 1 month and 3 months after a myocardial infarction treated with primary PCI to determine whether improvement at 1 month differs from improvement at 3 months.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Sherbrooke, Quebec, J1H 5N4, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 month post myocardial infarction
Left ventricular ejection fraction recuperation 1 month post myocardial infarction as compared with the left ejection fraction 3 months post myocardial infarction
Time frame: 1 month post myocardial infarction
Anterior and apical akinesis recuperation 1 month post myocardial infarction as compared with 3 months post myocardial infarction
Paul Farand
Other
Acronym: ROSE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03646760
Angina Pectoris, Arterial Occlusive Diseases
Detroit, Michigan, United States
View Trial DetailsNCT00041444
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT00442806
Arterial Occlusive Diseases, Arteriosclerosis
Rotterdam, Netherlands
View Trial DetailsNCT00005487
Arterial Occlusive Diseases, Arteriosclerosis
View Trial Details